Generation triple-targeting, chiral, broad-spectrum...

Details Generation triple-targeting, chiral, broad-spectrum... Generation triple-targeting, chiral, broad-spectrum...

2008-07-01

2008-07-01

Seaman, D. Margaret (Department: 1625)

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

C514S312000

Reexamination Certificate

active

07393957

ABSTRACT:
This invention relates to new generation triple-targeting, chiral, broad-spectrum antimicrobial 7-substituted piperidino-quinolone carboxylic acid derivatives, to their optical isomers, diastereomers or enantiomers, as well as pharmaceutically acceptable salts, hydrates, prodrugs, polymorphs and pseudopolymorphs thereof, to their preparation, to their compositions and to their use.

REFERENCES:
patent: 3536809 (1970-10-01), Applezweig
patent: 3598123 (1971-08-01), Zaffaroni
patent: 3845770 (1974-11-01), Theeuwes et al.
patent: 3916899 (1975-11-01), Theeuwes et al.
patent: 3924042 (1975-12-01), Gerster et al.
patent: 3984403 (1976-10-01), Fujisawa et al.
patent: 3985882 (1976-10-01), Gerster et al.
patent: 4008719 (1977-02-01), Theeuwes et al.
patent: 4051247 (1977-09-01), Schuppan et al.
patent: 4382892 (1983-05-01), Hayakawa et al.
patent: 4399134 (1983-08-01), Ishikawa et al.
patent: 4404207 (1983-09-01), Stern
patent: 4416884 (1983-11-01), Ishikawa et al.
patent: 4443447 (1984-04-01), Gerster et al.
patent: 4472406 (1984-09-01), Gerster et al.
patent: 4472407 (1984-09-01), Stern et al.
patent: 4535161 (1985-08-01), Hayakawa et al.
patent: 4552879 (1985-11-01), Ishikawa et al.
patent: 4563459 (1986-01-01), Groher et al.
patent: 4594347 (1986-06-01), Ishikawa et al.
patent: 4599418 (1986-07-01), Irikura et al.
patent: 4638067 (1987-01-01), Culbertson et al.
patent: 4642355 (1987-02-01), Nakamura et al.
patent: 4665079 (1987-05-01), Culbertson et al.
patent: 4777175 (1988-10-01), Culbertson et al.
patent: 4822801 (1989-04-01), Domagala et al.
patent: 4874764 (1989-10-01), Ueda et al.
patent: 4880806 (1989-11-01), Ueda et al.
patent: 4894458 (1990-01-01), Masuzawa et al.
patent: 4935420 (1990-06-01), Ueda et al.
patent: 4997943 (1991-03-01), Iwata et al.
patent: 5051509 (1991-09-01), Nagano et al.
patent: 5097032 (1992-03-01), Domagala et al.
patent: 5185337 (1993-02-01), Fujii et al.
patent: 5290934 (1994-03-01), Ueda et al.
patent: 5348961 (1994-09-01), Iwata et al.
patent: 5420140 (1995-05-01), Perrin
patent: 5436367 (1995-07-01), Iwata et al.
patent: 5607942 (1997-03-01), Petersen et al.
patent: 5639886 (1997-06-01), Zerbes et al.
patent: 5677316 (1997-10-01), Ao et al.
patent: 5859026 (1999-01-01), Ito et al.
patent: 5869661 (1999-02-01), Ochi et al.
patent: 5889009 (1999-03-01), Miyake et al.
patent: 6034100 (2000-03-01), Adachi et al.
patent: 6121285 (2000-09-01), Takemura et al.
patent: 6136806 (2000-10-01), Hittel
patent: 6184388 (2001-02-01), Takemura et al.
patent: 6329391 (2001-12-01), Ledoussal et al.
patent: 6514986 (2003-02-01), de Souza et al.
patent: 6608078 (2003-08-01), De Souza et al.
patent: 7098219 (2006-08-01), de Souza et al.
patent: 0230295 (1987-07-01), None
patent: 0241206 (1987-10-01), None
patent: 0287951 (1988-10-01), None
patent: 0300735 (1989-01-01), None
patent: 0304087 (1989-02-01), None
patent: 0342675 (1989-11-01), None
patent: 0541086 (1993-05-01), None
patent: 0572259 (1993-12-01), None
patent: 0394553 (1995-06-01), None
patent: 0908181 (1999-04-01), None
patent: 0919553 (1999-06-01), None
patent: 57081486 (1982-05-01), None
patent: 57176987 (1982-10-01), None
patent: 58090511 (1983-05-01), None
patent: 63192753 (1988-08-01), None
patent: 02131483 (1990-05-01), None
patent: 02188570 (1990-07-01), None
patent: 02188589 (1990-07-01), None
patent: 05339238 (1993-12-01), None
patent: 6-145167 (1994-05-01), None
patent: 9414794 (1994-07-01), None
patent: 9415938 (1994-07-01), None
patent: 9420105 (1994-09-01), None
patent: 9724128 (1997-07-01), None
patent: 9731000 (1997-08-01), None
patent: 9744034 (1997-11-01), None
patent: 9858923 (1998-12-01), None
patent: 9914214 (1999-03-01), None
patent: 9926940 (1999-06-01), None
patent: 0018404 (2000-04-01), None
patent: 0068229 (2000-11-01), None
patent: 0185095 (2001-11-01), None
patent: 0185728 (2001-11-01), None
patent: 0209758 (2002-02-01), None
European Patent Specification 0394553 B1, dated Jun. 21, 1995.
Alsina J. et al. “Active Carbonate Resins for Solid-Phase Synthesis Through the Anchoring of a Hydroxyl Function. Synthesis of Cyclic and Alcohol Peptides”,Tetrahedron Letters, (1997), 38(5): 883-886.
Edwards W.B. et al. “Generally Applicable, Convenient Solid-Phase Synthesis and Receptor Affinities of Octreotide Analogs”,J. Med. Chem., (1994), 37(22): 3749-3757.
Dhople, A.M. and M.A. Tbanez. “In vivo susceptibility ofMycobacterium lepraeto ofloxacin either singly or in combination with Rifampicin and Rifabutin”,Arzneimittel-Forschung., (1994), 44(4): 563-565.
Haustein U.F. et al. “Topical quinolone nadifloxacin (OPC-7251) in bacterial skin disease: clinical evaluation in a multicenter open trial and in vitro antimicrobiological susceptibility testing”,J. Dermatological Treatment, (1997), 8: 87-92.
Hashimoto, Koji et al. “A Practical Synthesis of (S)-(-)-Nadifloxacin: Novel Acid-Catalyzed Racemization of Tetrahydroquinaldine Derivative”,Chem. Pharm. Bull., (1996), 44(4): 642-645.
Irish, D. et al. “Control of an outbreak of an epidemic methicillin-resistantStaphylococcus aureusalso resistant to mupirocin”,J. Hospital Infection, (1998), 39: 19-26.
Kido, M. et al. “Crystal Structures of Nadifloxacin Anhydride and its Hemihydrate”,Chem. Pharm. Bull., (1994), 42(4):872-876.
Takahashi et al. “Reduction of in vitro Clastogenicity Induced by the Mixture of Optical Isomers of Nadifloxacin during Storage”,Arzneim.-Forsch./Drug Res., (1995), 45(1): 195-197.
Sloan et al. “Definition and attainment of high purity of organic compounds”, Chapter 2, 179-182,Physical and Chemistry of the Organic Solid State, eds. D. Fox, Labes and Weissberer. Interscience Publishers, London. 1963.
Morita, S. et al. “An efficient synthesis of a key determinate towards (S)-(-)-Nadifloxacin”,Tetrahedron: Asymmetry, (1995), 6(1): 245-254.
Morita, S. et al. “Synthesis and Antibacterial Activity of the Metabolites of 9-Fluoro-6,7-dihydro-8-(4-hydroxy-1-piperidyl)-5-methyl-1-oxo-1H,5H-benzo[,j]quinolizine-2-carboxylic acid (OPC-7251)”,Chem. Pharm.Bull., (1990), 38(7): 2027-2029.
Ishikawa, H. et al. “Studies on Antibacterial agents. I. Synthesis of Substituted 6,7-Dihydro-1-oxo-1H,5H-benzo[i,j]-quinolizine-2-carboxylic acids”,Chem. Pharm. Bull., (1989), 37(8): 2103-2108.
English translation of Yamada, Hirao et al. “Evaluation of the in vitro drug efficacy of Nadifloxacin Cream”,Iyakuhin Kenkyu, (2000), 31(8): 519-524.
English abstract of Japanese patent 02131483, dated May 21, 1990.
English abstract of Japanese patent 02188589, dated Jul. 24, 1990.
English translation of Yamada, Hiroaki, et al. “Bioequivalency of 1 % Nadifloxacin lotion and 1 % of Nadifloxacin cream”,Iyakuhin Kenkyu, (2000), 31(8): 525-528.
Berge, Stephen M. et al. “Pharmaceutical Salts”,J. Pharmaceutical Sciences, (1977), 66(1): 1-19.
Abstract of Koike, M. et al.Iyakuhin Kenkyu, (1990), 21(5): 998-1021.
Abstract of Koike, M. et al.Iyakuhin Kenkyu, (1990), 21(5): 1022-1033.
Abstract of Fujita, S. et al.Iyakuhin Kenkyu, (1990), 21(6): 1158-1176.
Abstract of Koike, M. et al.Yakubutsu Dotai, (1990), 5(2): 199-208.
Abstract of Yasuo, A. et al.Yakuri to Chiryo, (1990), 18(4): 1717-1730.
Abstract of Hayakawa, R. et al.Hifu, (1990), 32(2): 217-230.
Abstract of Asada, Y. et al.Yakuri to Chiryo, (1990), 18(4): 1717-1730.
Abstract of Awogi, T. et al.Iyakuhin Kenkyu, (1990), 21(4): 626-635.
Abstract of Matsuzawa, A. et al.Iyakuhin Kenkyu. (1990), 21(4): 636-646.
Abstract of Nagao, T. et al.Iyakuhin Kenkyu, (1990), 21(4): 647-662.
English abstract of WO 97/44034, dated Nov. 27, 1997.
English abstract of JP 5339238, dated Dec. 21, 1993.
English abstract of JP 58090511, dated May 30, 1983.
Abstract of Matsuzawa, A. et al.Iyakuhin Kenkyu, (1990), 21(4): 663-670.
Abstract of Hashimoto, K. et al.Iyakuhin Kenkyu, (1990), 21(4): 671-677.
Abstract of Furukawa, M. et al.Iyakuhin Kenkyu, (1990), 21(5): 989-997.
Abstract of Yoshimura, S. et al.Iyakuhin Kenkyu, (1990), 21(5): 1034-1052.

Affiliated with

Also associated with

Rating

Generation triple-targeting, chiral, broad-spectrum... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Generation triple-targeting, chiral, broad-spectrum..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Generation triple-targeting, chiral, broad-spectrum... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2812810